Mizoguchi H, Imagawa M, Fukunaga Y, Nomura Y, Kubota M, Okita J
Department of Urology, Oita Medical University, Japan.
Nihon Hinyokika Gakkai Zasshi. 1995 Dec;86(12):1757-60. doi: 10.5980/jpnjurol1989.86.1757.
We studied the clinical efficacy of sclerotherapy with injection of 3% polidocanol for hydrocele testis.
From July, 1992 to March, 1995 sclerotherapy with single injection of polidocanol was performed for 11 patients with 12 hydrocele testis on an outpatient basis. We instilled 3 or 5ml of 3% polidocanol after complete removal of fluid in the hydrocele testis.
Complete disappearance on ultrasonography was observed in 75% of the hydrocele testis 6 months after this sclerotherapy. There was neither pain during instillation of 3% polidocanol nor any other complication. Two patients with fluid reaccumulation underwent hydrocelectomy 16 and 6 months after sclerotherapy, respectively.
This procedure seems to be a safe and useful technique as primary treatment for hydrocele testis.
我们研究了注射3%聚多卡醇硬化治疗睾丸鞘膜积液的临床疗效。
1992年7月至1995年3月，对11例（12侧）睾丸鞘膜积液患者在门诊进行了单次注射聚多卡醇硬化治疗。在完全抽净睾丸鞘膜积液内的液体后，注入3或5毫升3%聚多卡醇。
硬化治疗6个月后，75%的睾丸鞘膜积液在超声检查中完全消失。注射3%聚多卡醇时既无疼痛，也未出现任何其他并发症。2例积液复发的患者分别在硬化治疗后16个月和6个月接受了鞘膜切除术。
该方法似乎是一种安全有效的睾丸鞘膜积液初始治疗技术。
